about
New aqueous inflow inhibitors.Short- and long-term safety of glaucoma drugs.Emerging drugs for ophthalmic diseases.Brimonidine for glaucoma.Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.Eyelid Make-Up to Manage Transient Blepharoptosis After Botulinum Toxin Injection.Glaucoma-Intraocular Pressure Reduction.
P2860
Q33903303-513D2AE4-163B-4A80-A049-0C88307EED5EQ35194520-DB3E8A12-4C66-437B-85D9-10BD03C1CB07Q35581180-F914DC0B-2E9E-4090-B83C-E5229A070582Q37724357-E72DC457-A978-4F35-A04C-B134A03B53ABQ37856242-04EA7FBA-9100-4A47-AE14-2F1317705948Q50068078-E997036F-8BED-4F20-89F0-F83FB59C6364Q53555670-EEB86E28-4286-4ED4-B2B6-9787716758CF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1995
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long term effect of apraclonidine.
@en
Long term effect of apraclonidine.
@nl
type
label
Long term effect of apraclonidine.
@en
Long term effect of apraclonidine.
@nl
prefLabel
Long term effect of apraclonidine.
@en
Long term effect of apraclonidine.
@nl
P2093
P2860
P356
P1476
Long term effect of apraclonidine.
@en
P2093
P2860
P304
P356
10.1136/BJO.79.12.1098
P407
P577
1995-12-01T00:00:00Z